Coloplast logo

Coloplast

CLPBY | OTC
Chart Builder DCF Calculator
$7.46
-$0.03 (-0.40%)
At close: Nov 16, 2026, 3:58 PM ET
$7.46
$0.00 (0.00%)
After-hours: Nov 16, 2026, 3:58 PM ET
-0.40%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
52.6
Fundamentals Average
Market Sentiment Neutral
Moat Wide
Sector Rank #223/1021 (Top 22%)

Key Statistics

Market Data

Market Cap $16.81B
1D Range
7.45 7.54
52W Range
5.69 9.23

Valuation (TTM)

PE 35.17
PB 7.76
EV/EBITDA 11.42

Valuation (NTM)

Forward PE 20.10
Forward PEG -32.90
Price Target $7.38
Loading financial charts...

Profile

Coloplast A/S, founded in 1954 and headquartered in Humlebæk, Denmark, operates as a global developer and marketer of intimate healthcare products and services. Its extensive reach spans Denmark, the ...

Sector Healthcare
Employees 16,907
IPO Date Jan 13, 2014
Fiscal Year October - September

Latest News

Coloplast: Turnaround Is Underway, But Upside Is Limited

6 days ago · seekingalpha.com

Coloplast: Turnaround Is Underway, But Upside Is Limited
Coloplast A/S (CLPBY) Q4 2026 Earnings Call Transcript

14 days ago · seekingalpha.com

Coloplast A/S (CLPBY) Q4 2026 Earnings Call Transcript
Coloplast pares back China operations as market recovery remains elusive

14 days ago · reuters.com

Coloplast pares back China operations as market recovery remains elusive
Coloplast A/S (CLPBY) Q3 2026 Earnings Call Transcript

3 months ago · seekingalpha.com

Coloplast A/S (CLPBY) Q3 2026 Earnings Call Transcript
Coloplast expects Kerecis wound-care unit to return to growth in 2027, CFO says

3 months ago · reuters.com

Coloplast expects Kerecis wound-care unit to return to growth in 2027, CFO says
Coloplast Might Have Found Its Bottom

3 months ago · seekingalpha.com

Coloplast Might Have Found Its Bottom

Earnings

Latest Earnings
Nov 3, 2026
EPS
$0.09
Beat +0.72%
REV
$1.12B
Miss -0.05%
Next Earnings
Feb 5, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.